Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)

Completed · Phase 3 · Has a placebo group

Conditions studied: Edematous Fibrosclerotic Panniculopathy, Cellulite

In brief

A Phase 3b, Open-Label Extension Study to evaluate safety and how long response of EN3835 (Collagenase Clostridium Histolyticum \[CCH\]-aaes) lasts in the treatment of Cellulite.

Key facts

Study ID
NCT03526549
Run by
Endo USA Inc., a Keenova Therapeutics Company
People needed
483
Starts
2018-04-26
Expected to finish
2021-10-08
Last updated by the study team
2023-09-08

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.